who should not use semaglutide for weight loss in non-diabetics Semaglutide Shines as Weight Loss

It is characterized by abdominal obesity, high blood pressure, high blood sugar, and abnormal cholesterol levels

However, thorough monitoring by a healthcare professional is required to minimize risks and ensure the safe and effective use of peptide dosing for fat loss

doi:10.6065/apem.2017.22.1.15

Likewise, Novo Nordisk which makes Ozempic also makes Wegovy, another semaglutide that is FDA-approved for weight loss

The endometrium may not develop properly without adequate estrogen, resulting in light or absent periods

Unfortunately, muscle loss can be a significant concern for individuals using these injectable medications